Hologic’s HOLX GYN Surgical segment posted fourth-quarter revenues of $172.5 million, up 10.2% year over year. This marked the strongest growth in fiscal 2025, as the company had earlier anticipated, ...
Hologic, Inc. HOLX recently announced the launch of new Fluent fluid management system in the United States. Per the company, this system is embedded with features that simplify and improvise the ...
The growing prevalence of gynecological diseases and increasing government investments to improve women’s health are fueling the demand for gynecology surgical instruments. According to Zion Market ...
MARLBOROUGH, Massachusetts, Jan. 3, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the MyoSure ® MANUAL device, which was designed to simplify tissue removal procedures ...
Hologic has agreed to pay $125 million to acquire privately held Interlace. The company makes the MyoSure hysteroscopic tissue removal system that helps easily remove fibroids and polyps. Hologic, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback